Pharmacokinetics, Efficacy, Tolerability and Safety of Different Budesonide Oral Gel Doses in Adults' Subjects of Both Genders With Eosinophilic Esophagitis (EoE)

Phase 2 Withdrawn Bazell Pharma AG

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A phase I/II, multicenter, double-blind, parallel, randomized trial to assess pharmacokinetics, efficacy, tolerability and safety of different budesonide oral gel doses in adults subjects of both genders with eosinophilic esophagitis (EoE)

Timeline

Start: 2021-04-23
Primary completion: 2024-11
Completion: 2025-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Budesonide	Small molecule	—	Oral

Pharmacokinetics, Efficacy, Tolerability and Safety of Different Budesonide Oral Gel Doses in Adults' Subjects of Both Genders With Eosinophilic Esophagitis (EoE)

Summary

Timeline

Drugs

Indications